Recent studies have shown that SIRT3 activation could alleviate the development of mouse hypertensive renal fibrosis by the suppression of endothelial-to-mesenchymal transition [12] and that the activation of SIRT3 signaling could ameliorate mouse injury induced by hypertension [13]. This evidence concerns the gene SIRT3 and hypertensive disorder.